Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)

被引：0

作者：

Morikawa, Kei ^{[1
]}

Takata, Saori ^{[2
]}

Tanaka, Hisashi ^{[3
]}

Horiuchi, Kazuya ^{[4
]}

Okuma, Yusuke ^{[5
]}

Soejima, Kenzo ^{[6
]}

Nakagawa, Hideyuki ^{[7
]}

Nakahara, Yoshiro ^{[8
]}

Seki, Yoshitaka ^{[9
]}

Bessyo, Akihiro ^{[10
]}

Takahashi, Nobumasa ^{[11
]}

Hayashi, Kentaro ^{[12
]}

Endo, Takeo ^{[13
]}

Takeyama, Ren ^{[14
]}

Maekura, Toshiya ^{[15
]}

Takigawa, Nagio ^{[16
]}

Horimoto, Katsuhisa ^{[17
]}

Matsutani, Noriyuki ^{[18
]}

Seki, Nobuhiko ^{[19
]}

机构：

[1] St Marianna Univ, Div Resp Dis, Dept Internal Med, Sch Med, Kawasaki, Kanagawa, Japan

[2] Kyorin Univ, Mitaka, Tokyo, Japan

[3] Hirosaki Univ, Hirosaki, Aomori, Japan

[4] Showa Univ, Northern Yokohama Hosp, Tokyo, Japan

[5] Natl Canc Ctr Hosp, Kashiwa, Chiba, Japan

[6] Keio Univ, Minato City, Japan

[7] Hirosaki Hosp, Hirosaki, Aomori, Japan

[8] Kitasato Univ, Minato City, Japan

[9] Jikei Univ, Hosp 3, Tokyo, Japan

[10] Okayama Red Cross Hosp, Okayama, Japan

[11] Saitama Cardiovasc & Resp Ctr, Saitama, Japan

[12] Nihon Univ, Chiyoda City, Japan

[13] Mito Med Ctr, Ibaraki, Japan

[14] Tokyo Womens Med Univ, Tokyo, Japan

[15] Hoshigaoka Med Ctr, Hirakata, Osaka, Japan

[16] Kawasaki Med Sch, Kawasaki, Kanagawa, Japan

[17] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan

[18] Teikyo Univ, Mizonokuti Hosp, Kawasaki, Kanagawa, Japan

[19] Teikyo Univ, Tokyo, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.244

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MO35-6

引用

页码：S1418 / S1419

页数：2

共 50 条

[1] Prospective exosome-focused translational research for afatinib study of non-small cell lung cancer patients expressing EGFR (EXTRA study)
Okuma, Yusuke
Morikawa, Kei
Tanaka, Hisashi
Yokoyama, Takuma
Itani, Hidetoshi
Horiuchi, Kazuya
Nakagawa, Hideyuki
Takahashi, Nobumasa
Bessho, Akihiro
Soejima, Kenzo
Kishi, Kazuma
Togashi, Akira
Kanai, Yae
Ueda, Koji
Horimoto, Katsuhisa
Matsutani, Noriyuki
Seki, Nobuhiko
THORACIC CANCER, 2019, 10 (02) : 395 - 400
[2] Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study
Takata, Saori
Morikawa, Kei
Tanaka, Hisashi
Itani, Hidetoshi
Ishihara, Masashi
Horiuchi, Kazuya
Kato, Yasuhiro
Ikemura, Shinnosuke
Nakagawa, Hideyuki
Nakahara, Yoshiro
Seki, Yoshitaka
Bessho, Akihiro
Takahashi, Nobumasa
Hayashi, Kentaro
Endo, Takeo
Takeyama, Kiyoshi
Maekura, Toshiya
Takigawa, Nagio
Kawase, Akikazu
Endoh, Makoto
Nemoto, Kenji
Kishi, Kazuma
Soejima, Kenzo
Okuma, Yusuke
Yoshimura, Kenichi
Saigusa, Daisuke
Kanai, Yae
Ueda, Koji
Togashi, Akira
Matsutani, Noriyuki
Seki, Nobuhiko
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[3] Prospective exosome-focused translational research for afatinib (EXTRA) study of patients with nonsmall cell lung cancer harboring EGFR mutation: an observational clinical study
Takata, Saori
Morikawa, Kei
Tanaka, Hisashi
Itani, Hidetoshi
Ishihara, Masashi
Horiuchi, Kazuya
Kato, Yasuhiro
Ikemura, Shinnosuke
Nakagawa, Hideyuki
Nakahara, Yoshiro
Seki, Yoshitaka
Bessho, Akihiro
Takahashi, Nobumasa
Hayashi, Kentaro
Endo, Takeo
Takeyama, Kiyoshi
Maekura, Toshiya
Takigawa, Nagio
Kawase, Akikazu
Endoh, Makoto
Nemoto, Kenji
Kishi, Kazuma
Soejima, Kenzo
Okuma, Yusuke
Yoshimura, Kenichi
Saigusa, Daisuke
Kanai, Yae
Ueda, Koji
Togashi, Akira
Matsutani, Noriyuki
Seki, Nobuhiko
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
[4] A Multicenter Prospective Biomarker Study in Afatinib-Treated Patients with EGFR-Mutation Positive Non-Small Cell Lung Cancer
Azuma, Koichi
Iwama, Eiji
Sakai, Kazuko
Nozaki, Kaname
Harada, Daijiro
Hotta, Katsuyuki
Ohyanagi, Fumiyoshi
Kurata, Takayasu
Akamatsu, Hiroaki
Goto, Koichi
Fukuhara, Tatsuro
Nakanishi, Yoichi
Okamoto, Isamu
Nishio, Kazuto
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S299 - S299
[5] A multicenter prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung cancer
Iwama, E.
Sakai, K.
Azuma, K.
Nosaki, K.
Harada, D.
Hotta, K.
Ohyanagi, F.
Kurata, T.
Akamatsu, H.
Goto, K.
Fukuhara, T.
Nakanishi, Y.
Nishio, K.
Okamoto, I.
ANNALS OF ONCOLOGY, 2015, 26 : 148 - 149
[6] A prospective biomarker study in afatinib-treated patients with EGFR-mutation positive non-small cell lung
Iwama, Eiji
Sakai, Kazuko
Azuma, Koichi
Nozaki, Kaname
Harada, Daijiro
Hotta, Katsuyuki
Ohyanagi, Fumiyoshi
Nakanishi, Yoichi
Nishio, Kazuto
Okamoto, Isamu
ANNALS OF ONCOLOGY, 2015, 26 : 83 - 83
[7] AFATINIB FOR THE TREATMENT OF PATIENTS WITH EGFR-POSITIVE NON-SMALL CELL LUNG CANCER
Bowles, D. W.
Weickhardt, A.
Jimeno, A.
DRUGS OF TODAY, 2013, 49 (09) : 523 - 535
[8] Afatinib in EGFR mutation positive advanced non-small cell lung cancer
Davies, R. S.
Brewster, A. E.
Button, M. R.
Lester, J. F.
LUNG CANCER, 2016, 91 : S22 - S22
[9] Phase I Study of Afatinib Plus Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutations
Tokito, T.
Ko, R.
Imamura, C.
Shukuya, T.
Shimada, N.
Koyama, R.
Yamada, K.
Ishii, H.
Azuma, K.
Takahashi, K.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S565 - S565
[10] Afatinib in non-small cell lung cancer
Wood, G. E.
Polychronis, A.
LUNG CANCER, 2016, 91 : S23 - S23

← 1 2 3 4 5 →